Navigation Links
Jumping The Queue Has Left Hospital Suspending Transplantation

In the US one of the top organ transplant hospitals in California has suspended its liver program following allegations a Saudi national improperly received an organ ahead of dozens of other needy American patients.//

The Los Angeles Times reported that officials at St. Vincent Medical Center also discovered that, following the transplant, some hospital staff allegedly falsified records of the operation on numerous occasions, ostensibly to shield the process from scrutiny or discovery.

The Saudi national, who was not identified, was No. 52 on the regional waiting list, which covered much of southern California. The liver should have gone instead to a patient at UCLA Medical Center.

There were no details on the disposition of that patient, or the patient who ultimately received the organ, and it was unclear how long St. Vincent's suspension would last. Hospital officials said they were in the process of notifying all organ transplant patients of the suspension.

Transplant patients are ranked according to severity of disease, which has been on the list the longest, whether or not they can hold up under major surgery and whether they can take the organ immediately.

Improper operation was discovered only in September month, in response to a routine audit by the United Network for Organ Sharing, the nonprofit organization that manages the national donation program
'"/>




Page: 1

Related medicine news :

1. Jumping genes eliminate sections of DNA
2. Chemotherapy Queues in Ontario Stay Steady
3. Two New Anesthesia Positions Promise to Ease Surgery Queue
4. Oracle Corp. to help build worlds first "Digital Hospital"
5. Apollo Hospitals to consider listing on US Bourses in 2003
6. The World Bank funds private Hospital in India
7. Link Between Hyperglycemia & Hospital Mortality
8. Reducing The Rate Of Hospital Acquired Infections
9. Home-based Treatment For Eczema More Effective Compared To Hospital Care
10. Hospital asked to Compensate Victim – Judgment by Delhi High Cour
11. Apollo Hospitals Collaborates With Histostem For Stem Cell Therapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and ... in Mystic, CT. Covering the process and maintenance strategies of gum grafting and ... periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists in ...
(Date:6/27/2017)... Los Angeles, CA (PRWEB) , ... June 27, 2017 , ... ... on what crooked bites can indicate about early life experiences. What happens to a ... study reveals that stresses after birth can also take a toll on a baby’s ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology: